期刊文献+

帕金森病小鼠模型行为学检测方法的比较研究 被引量:19

Comparison of Behavioral Tests in MPTP-induced Parkinson's Disease in Mice
下载PDF
导出
摘要 目的比较目前常用的5种帕金森病(PD)小鼠模型行为学检测方法在PD研究中的作用。方法用MPTP建立C57BL小鼠PD模型,通过行为学检测(自主活动计数、滚轴实验、游泳实验、爬杆实验、悬挂实验)、免疫组织化学和荧光分光光度法,对比5种行为学检测方法的平均数与变异系数,观察MPTP对PD小鼠模型的行为学、黑质多巴胺(DA)神经元和纹状体酪氨酸羟化酶免疫反应阳性(TH-ir)神经纤维以及纹状体DA水平的影响。结果给与MPTP后,小鼠行为学计数降低,爬杆实验未能得到检测结果,悬挂实验变异系数很高,结果有明显的偶然性,滚轴实验结果变异系数中等,平均数呈现一定的上升趋势,自主活动计数中移动与站立和游泳实验的平均数则呈现明显的下降趋势,变异系数很低,而黑质DA神经元数目减少约58%,纹状体TH-ir神经纤维密度减低,纹状体DA水平明显降低约88%,两组相比差异有显著性(P<0.01)。结论MPTP所致的C57BL小鼠的神经病理、生化改变与PD患者近似,自主活动计数和游泳实验优于其他行为学检测方法。 Objective To study the different role of 5 behavioral tests on 1-methyl-4-phenyl-1 ,2,3,6-tetrahydrepyridine (MPTP)-induced Parkinson's disease(PD) in C57BL mice. Methods The PD models were formed with intraperitoneal injections of MPTP. The effects of MPTP on behavioral exhibition, number of dopamine (DA) neurons in the substantia nigra and density of tyrosine hydroxylase-immunoreactive (TH-ir) nerve fibers in the striatum, level of DA in the striatum were studied by comparing 5 behavioral tests (open field, retarod, swim test, pole test, grid test), immunohistochemical analysis and fluorespectrophotometry. Results The score of behavioral tests were declined after MPTP. But there was no efficient result in pole test. At the same time, there were high coefficient of variation (CV) and accidental result in grid test. The CV was intermediate and the result was moderately ascending in retared. In open field and swim test, the CV was low and the result was obviously downtrend. The number of DA neurons in the substantia nigra were decreased about 58%. The density of TH-ir nerve fibers was also showed to be reduced. The level of DA in the striatum were decresased about 88%. Conclusion The lesions induced by MPTP in C57BL mice are similar to PD in humans. Open field and swim tests are better than others in behavioral tests of studying MPTP-induced PD in C57BL mice.
出处 《中国实验动物学报》 CAS CSCD 2006年第4期264-270,共7页 Acta Laboratorium Animalis Scientia Sinica
关键词 帕金森病 1-甲基-4-苯基-1 2 3 6-四氢吡啶 行为 动物模型 小鼠 Parkinson's disease MPTP Behavior Models, Animal Mice
  • 相关文献

参考文献13

  • 1Kawai H, Makino Y, Hirobe M, et al. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism[J]. J Neurochem, 1998, 70:745-751.
  • 2Dorman GA, Willis GL, Kaczmarczyk SJ, et al. Motor function in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mouse [J]. J Neurol Sci. 1987, 77(2-3):185-191.
  • 3Ogawa N, Hirose Y, Ohara S, et al. A simple quantitative bradykinesia test in MPTP-treated mice [J]. Res Commun Chem Pathol Pharmacol. 1985, 50(3) :435-441.
  • 4Kuribara H, Higuchi Y, Tadokoro S. Effects of central depressants on rota-rod and traction performances in mice[J]. Jpn J Pharmacol.1977, 27(1):117-126.
  • 5Sedelis M, Schwarting RK, Huston JP. Behavioral phenotyping of the MPTP mouse model of Parkinson' s disease [ J ]. Behav Brain Res. 2001, 125(1-2):109-125.
  • 6Matsuura K, Kabuto H, Makino H, et al. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion[J]. J Neurosci Methods. 1997, 73( 1 ) :45-48.
  • 7Tillerson JL, Caudle WM, Reveron ME, et al. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine[J]. Exp Neurol. 2002, 178(1):80-90.
  • 8Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism[J]. J Neurosci Methods. 2003, 123(2):189-200.
  • 9Rozas G, Liste I, Guerra MJ, et al. Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice[J]. Neurosci Lett. 1998 , 245(3):151-154.
  • 10Rozas G, Lopez-Martin E, Guerra MJ, et al. The overall rod pedormance test in the MPTP-treated-mouse model of Parkinsonism[J]. J Neurosci Methods. 1998, 83(2):165-175.

二级参考文献31

  • 1Schmidt N,Ferger B.Neurochemical findings in the MPTP model of Parkinson's disease.J Neural Transmission[J],2001,108:1263-1282.
  • 2Robinson S,Freeman P,Moore C,et al.Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function[J].Exp Neurol,2003,180:73-86.
  • 3Rousselet E,Joubert C,Callebert J,et al.Behavioral changes are not directly related to striatal monoamine levels,number of nigral neurons,or dose of parkinsonian toxin MPTP in mice[J].Neurobiol Dis,2003,14:218-228.
  • 4Tillerson JL,Miller GW.Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of parkinsonism[J].J Neurosci Methods,2003,123:189-200.
  • 5Langston JW,Forno LS,Tetrud J,et al.Evidence of active nerve cell degeneration in the substantia nigra of humans years after1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure [ J ].Ann Neurol,1999,46:598-605.
  • 6Araki T,Mikami T,Tanji H,et al.Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse [ J ].Eur J Pharmaceut Sci,2001,12:231-238.
  • 7Hofele K,Sedelis M,Auburger GW,et al.Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility[J].Exp Neurol,2001,168:116-122.
  • 8Bezard E,Dovero S,Bioulac B,et al.Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice[J].Exp Neurol,1997,148:288-292.
  • 9Smith TS,Trimmer PA,Khan SM,et al.Mitochondrial toxins in models of neurodegenerative diseases.Ⅱ:Elevated zif268transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP-treatment[J].Brain Research,1997,765:189-197.
  • 10Tanji H,Araki T,Nagasawa H,et al.Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP[J].Brain Res,1999,824:224-231.

共引文献12

同被引文献219

引证文献19

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部